| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_449898f4ff389ba06802c9f48c6a132c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2001-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5636ae1b8c0129c5fecb11d5a419fd92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ebc0b6ed01875d5f02097bab13269e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8922e8719b87862f8a468e4c5a250f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a724f51b839700cace3a8d2e74c026b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f794f0c14ec330ac223e911123acd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a5fb05da005a021c0005674aaf87a2b |
| publicationDate |
2003-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1251842-B1 |
| titleOfInvention |
Use of modafinil for the manufacture of a medicament for correcting vigilance disorders related to myopathies |
| abstract |
The present invention relates to the use of modafinil and isomers thereof for correcting psychosocial life disturbances due to vigilance disorders observed during the evolution of myopathies. |
| priorityDate |
2000-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |